Capital Performance Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-63
Closed -$1.84K 845
2024
Q3
$1.84K Buy
+63
New +$1.84K ﹤0.01% 1604